# FDA Inspection 1073797 - Daiichi Sankyo Europe GmbH - October 19, 2018

Source: https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/cd18cb9e-a7b8-4e13-b0b3-97e8c2e677a4
Source feed: FDA_Inspections

> FDA Inspection 1073797 for Daiichi Sankyo Europe GmbH on October 19, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1073797
- Company Name: Daiichi Sankyo Europe GmbH
- Inspection Date: 2018-10-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1275919 - 2025-07-18](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/02cc4ef0-7e2f-4314-a0e8-7193ad8f6f8f)
- [FDA Inspection 882156 - 2014-05-15](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/be78a751-86d5-4f80-8db5-7d35b11742e6)
- [FDA Inspection 802508 - 2012-09-20](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/e6cefea5-b87a-4664-869f-ead78f0482a8)
- [FDA Inspection 649526 - 2010-01-29](https://www.keypedia.com/records/fda_inspections/daiichi-sankyo-europe-gmbh/26f9628c-64d1-415c-9547-71f547d8540b)

Company: https://www.keypedia.com/companies/daiichi-sankyo-europe-gmbh/772636a4-cbb8-47ae-8aa1-fdc45ab325f6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c